Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
AD ›
ADRAMEL
Trademark search for:
ADRAMEL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-12-14 — Application filed
2016-12-17 — Application filed
2016-12-20 — Application filed
2017-03-16 — Assigned to examiner
2017-03-21 — Approved for pub - principal register
2017-04-12 — Notification of notice of publication e-mailed
2017-05-02 — Published for opposition
2017-05-02 — Official gazette publication confirmation e-mailed
2017-06-27 — Noa e-mailed - sou required from applicant
2017-12-20 — Sou teas extension received
2017-12-20 — Sou extension 1 filed
2017-12-20 — Sou extension 1 granted
2017-12-22 — Notice of approval of extension request e-mailed
2018-06-21 — Teas change of correspondence received
2018-06-21 — Sou teas extension received
2018-06-21 — Sou extension 2 filed
2018-06-21 — Sou extension 2 granted
2018-06-23 — Notice of approval of extension request e-mailed
2018-12-19 — Sou teas extension received
2018-12-19 — Sou extension 3 filed
2018-12-19 — Sou extension 3 granted
2018-12-21 — Notice of approval of extension request e-mailed
2019-06-25 — Sou teas extension received
2019-06-25 — Sou extension 4 filed
2019-06-25 — Sou extension 4 granted
2019-06-25 — Teas change of correspondence received
2019-06-27 — Notice of approval of extension request e-mailed
2019-12-18 — Sou teas extension received
2019-12-18 — Sou extension 5 filed
2019-12-30 — Case assigned to intent to use paralegal
2019-12-30 — Sou extension 5 granted
2019-12-31 — Notice of approval of extension request e-mailed
2020-08-03 — Application abandoned
2020-08-03 — Application abandoned
2020-08-03 — Final status recorded
Owner Information
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc.
Correspondent
Laurence Rickles TEVA PHARMACEUTICALS USA, INC.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
